Blackstone’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
ACA
Blackstone's CRDF Position: Q3 2025 in Review
Blackstone sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 158,330 shares — an estimated $499K sold.
Blackstone first reported a position in CRDF in Q4 2024 and held it in 3 quarters. The position peaked at $499K in Q2 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.
- Blackstone reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
- Blackstone sold 158,330 Cardiff Oncology shares in Q3 2025, an estimated $499K.
- Blackstone first reported a position in Cardiff Oncology in Q4 2024 and held it in 3 quarters.
- Blackstone's Cardiff Oncology position peaked at $499K in Q2 2025.
- 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.
Based on Blackstone's 13F filing for Q3 2025, filed 14 Nov 2025.